4.6 Article

Clinical outcomes of COVID-19 in hemodialysis patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Urology & Nephrology

Increased risk of dialysis circuit clotting in hemodialysis patients with COVID-19 is associated with elevated FVIII, fibrinogen and D-dimers

Dinesha Sudusinghe et al.

Summary: There is an association between COVID-19 and circuit clotting, as HD patients with COVID-19 experienced increased circuit clotting within 4 weeks of infection. The risk of circuit clotting was related to increased factor VIII, fibrinogen, and D-dimer levels, indicating an inflammatory response to COVID-19.

HEMODIALYSIS INTERNATIONAL (2023)

Review Oncology

ABO blood group association and COVID-19. COVID-19 susceptibility and severity: a review

Sapha Shibeeb et al.

Summary: The global impact of the COVID-19 pandemic since the end of 2019 has led to investigations on the potential influence of the ABO blood group system on susceptibility and disease progression. Different blood groups may have varying risks and outcomes when infected with SARS-CoV-2.

HEMATOLOGY TRANSFUSION AND CELL THERAPY (2022)

Article Urology & Nephrology

Acute ischemic events after COVID-19 infection in patients undergoing maintenance hemodialysis

Etem Ozkaya et al.

Summary: A significant number of maintenance hemodialysis patients developed acute ischemic complications weeks to months after COVID-19 resolution. Specific interventions may be needed to prevent subsequent acute ischemic events in these patients.

HEMODIALYSIS INTERNATIONAL (2022)

Article Urology & Nephrology

Increased 1-year mortality in haemodialysis patients with COVID-19: a prospective, observational study

Sol Carriazo et al.

Summary: The mortality rate of hemodialysis patients with COVID-19 is high and not limited to the initial hospitalization. Defining COVID-19 deaths as those occurring within 3 months of a COVID-19 diagnosis may better represent the burden of COVID-19. The immune response to SARS-CoV-2 in hemodialysis patients is suboptimal and short-lived.

CLINICAL KIDNEY JOURNAL (2022)

Article Urology & Nephrology

COVID-19-related clinical outcomes among Korean hemodialysis patients

Hayne Cho Park et al.

Summary: This retrospective cohort study examines the clinical outcomes and associated factors of COVID-19 in hemodialysis (HD) patients in Korea. The study finds that HD patients have a higher risk of in-hospital mortality and morbidity from COVID-19, especially among older patients or those presenting with symptoms.

KIDNEY RESEARCH AND CLINICAL PRACTICE (2022)

Article Urology & Nephrology

AKI in Hospitalized Patients with COVID-19

Lili Chan et al.

Summary: The study found that AKI is common among hospitalized COVID-19 patients in the United States, with a 46% occurrence rate and 19% of patients requiring dialysis. Independently predicting severe AKI were chronic kidney disease, male gender, and higher serum potassium levels at admission. In-hospital mortality was significantly higher in patients with AKI compared to those without AKI, with only 30% of AKI patients recovering kidney function by the time of discharge.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Article Surgery

Is COVID-19 infection more severe in kidney transplant recipients?

Sophie Caillard et al.

Summary: Transplant recipients had a higher COVID-19-related mortality compared to nontransplant hospitalized patients but did not differ significantly in the rate of severe disease. Factors associated with severe COVID-19 included age, cardiovascular disease, dyspnea, fever, lymphopenia, and CRP.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Review Hematology

COVID-19 in ESRD and Acute Kidney Injury

Jeroen P. Kooman et al.

Summary: The COVID-19 pandemic has had a significant impact on nephrology, with dialysis patients and those with COVID-19-related acute kidney injury being more susceptible to viral infection and disease progression, presenting challenges in treatment.

BLOOD PURIFICATION (2021)

Article Urology & Nephrology

Hypokalemia in Patients with COVID-19

Gaetano Alfano et al.

Summary: Hypokalemia is a common disorder in patients with COVID-19, with a prevalence of 41%. Female sex and diuretic therapy were identified as risk factors for low serum potassium levels. Hypokalemia was not associated with ICU transfer and death in this cohort of patients.

CLINICAL AND EXPERIMENTAL NEPHROLOGY (2021)

Article Urology & Nephrology

The risk factors associated with COVID-19-Related death among patients with end-stage renal disease

Hadith Rastad et al.

Summary: Patients with End-stage renal disease (ESRD) are at a higher risk of COVID-19-related death, especially those who are older than age 65 years and presented with symptoms such as lack of consciousness or O2 saturation less than 93%.

BMC NEPHROLOGY (2021)

Article Urology & Nephrology

Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19

Kenan Turgutalp et al.

Summary: This study revealed a high mortality rate among hospitalized MHD patients with COVID-19. Risk factors for mortality included older age, heart failure, disease severity, ferritin level, platelet count decrease, and AST level increase.

BMC NEPHROLOGY (2021)

Editorial Material Medicine, General & Internal

Myocardial Infarction During the COVID-19 Pandemic

Alexander C. Fanaroff et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Urology & Nephrology

Role of blood pressure dysregulation on kidney and mortality outcomes in COVID-19. Kidney, blood pressure and mortality in SARS-CoV-2 infection

Chiara Lanzani et al.

Summary: In patients hospitalized for COVID-19 in Milan, hypertension and low blood pressure at presentation are important risk factors for AKI and mortality. Early reduction of antihypertensive therapy may improve outcomes in patients with SARS-CoV-2 infection.

JOURNAL OF NEPHROLOGY (2021)

Article Urology & Nephrology

Age and multimorbidities as poor prognostic factors for COVID-19 in hemodialysis: a Lebanese national study

Mabel Aoun et al.

Summary: This study in Lebanon identified older age, coronary artery disease, heart failure, multimorbidities, fever, and pneumonia as risk factors for mortality in chronic hemodialysis patients with COVID-19. The adjusted regression analysis further confirmed the association between these factors and higher mortality rates. The death rate observed in this study was 23.8%, comparable to rates reported in other countries.

BMC NEPHROLOGY (2021)

Review Physiology

COVID-19 and Hypertension: The What, the Why, and the How

Shah-Abas Muhamad et al.

Summary: Observational studies globally have shown that most COVID-19 patients have preexisting hypertension, raising questions about the potential relationship between COVID-19 and hypertension. This review summarizes the current understanding of the link between hypertension and COVID-19, as well as its underlying mechanisms.

FRONTIERS IN PHYSIOLOGY (2021)

Letter Urology & Nephrology

Electrolyte abnormalities in patients hospitalized with COVID-19

Deepa A. Malieckal et al.

CLINICAL KIDNEY JOURNAL (2021)

Article Urology & Nephrology

Kidney Outcomes in Long COVID

Benjamin Bowe et al.

Summary: The study showed that survivors of COVID-19 had an increased risk of kidney outcomes in the post-acute phase of the disease, indicating the importance of paying attention to kidney disease in long-term COVID-19 care.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Review Surgery

Relationship between blood type and outcomes following COVID-19 infection

Young Kim et al.

Summary: Since the COVID-19 pandemic began, researchers have been focusing on investigating the risk factors of viral infection, severe illness, and death, with recent studies examining the association between blood type and COVID-19 infection. This article aims to comprehensively review current literature to better understand the impact of blood type on viral susceptibility and outcomes.

SEMINARS IN VASCULAR SURGERY (2021)

Review Physiology

Angiotensin-Converting Enzyme 2 in the Pathogenesis of Renal Abnormalities Observed in COVID-19 Patients

Nayara Azinheira Nobrega Cruz et al.

Summary: COVID-19, caused by SARS-CoV-2, has led to a major pandemic with a wide range of clinical manifestations, including severe respiratory syndrome and kidney injury. The high affinity of SARS-CoV-2 for ACE2 may contribute to the severity of the disease by depleting its biological activity and affecting renal physiology.

FRONTIERS IN PHYSIOLOGY (2021)

Review Urology & Nephrology

Risk factors for mortality in hemodialysis patients with COVID-19: a systematic review and meta-analysis

Fengping Wang et al.

Summary: Male patients with HD may have a higher risk of developing severe COVID-19. Respiratory diseases and clinical features such as fever, dyspnea, cough, and abnormal platelet, leucocyte, and albumin levels could greatly influence the clinical prognosis of COVID-19 in these patients. Our findings suggest that clinicians should pay attention to these markers to detect high mortality risk in HD patients early in the course of COVID-19.

RENAL FAILURE (2021)

Article Respiratory System

Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

Wei-jie Guan et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Editorial Material Urology & Nephrology

Minimizing the risk of COVID-19 among patients on dialysis

T. Alp Ikizler et al.

NATURE REVIEWS NEPHROLOGY (2020)

Review Immunology

COVID-19 pathophysiology: A review

Koichi Yuki et al.

CLINICAL IMMUNOLOGY (2020)

Review Medicine, General & Internal

COVID-19 and the kidney

Mohamed Hassanein et al.

CLEVELAND CLINIC JOURNAL OF MEDICINE (2020)

Review Medical Laboratory Technology

COVID-19: Transmission, prevention, and potential therapeutic opportunities

Melika Lotfi et al.

CLINICA CHIMICA ACTA (2020)

Article Biochemistry & Molecular Biology

Low serum calcium: a new, important indicator of COVID-19 patients from mild/moderate to severe/critical

Xi Zhou et al.

BIOSCIENCE REPORTS (2020)

Review Immunology

SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development

Mei-Yue Wang et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)